What is Citigroup's price target for CLB?

Citigroup's latest stated price target for Core Laboratories Inc. (CLB) is $16, from its action on Mar 12, 2025.

What is Citigroup's rating on CLB?

Citigroup rates CLB Neutral, a neutral rating, as of Mar 12, 2025.

When did Citigroup last change its view on CLB?

On Mar 12, 2025, Citigroup upgrades to Neutral from Sell, price target $15 to $16.

Citigroup CLB price target and rating history

Citigroup rates Core Laboratories Inc. (CLB) Neutral with a $16 price target, as of its latest action on Mar 12, 2025. It has published 3 rating actions on CLB since October 2022, including 2 upgrades and 1 downgrade.

Current rating: Neutral
Price target: $16
Median target, all firms: Too few
Actions on CLB: 3

Citigroup price target on CLB

Citigroup price target on CLB, each point a stated target, October 2022 to March 2025.

Every Citigroup rating on CLB

Mar 12, 2025
UpgradeCitigroup upgrades to Neutral from Sell, price target $15 to $16
Jun 30, 2023
DowngradeCitigroup downgrades to Sell from Neutral, price target $22 to $21
Oct 7, 2022
UpgradeCitigroup upgrades to Neutral from Sell, price target $24 to $17

Questions about Citigroup and CLB

What is Citigroup's price target for CLB?: Citigroup's latest stated price target for Core Laboratories Inc. (CLB) is $16, from its action on Mar 12, 2025.
What is Citigroup's rating on CLB?: Citigroup rates CLB Neutral, a neutral rating, as of Mar 12, 2025.
When did Citigroup last change its view on CLB?: On Mar 12, 2025, Citigroup upgrades to Neutral from Sell, price target $15 to $16.

More CLB rating histories

All Citigroup ratings CLB news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.